Aerie Pharmaceuticals Inc

SCHRODER INVESTMENT MANAGEMENT GROUP

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

1,500,183

Value ($000)

22,698

Weight

0.0%

2013 Q4 - 2022 Q3 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	22,698	0.0%	1,500,183	9/30/2022
2022 Q2	8/11/2022	15,711	0.0%	2,094,811	6/30/2022
2022 Q1	5/16/2022	21,403	0.0%	2,351,994	3/31/2022
2021 Q4	2/14/2022	9,498	0.0%	1,352,954	12/31/2021
2021 Q3	11/12/2021	15,196	0.0%	1,332,964	9/30/2021
2021 Q2	8/13/2021	22,404	0.0%	1,399,345	6/30/2021
2021 Q1	5/28/2021	25,223	0.0%	1,411,454	3/31/2021
2020 Q4	2/16/2021	18,954	0.0%	1,402,975	12/31/2020
2020 Q3	11/13/2020	13,714	0.0%	1,145,675	9/30/2020
2020 Q2	8/13/2020	16,473	0.0%	1,116,038	6/30/2020
2020 Q1	5/15/2020	13,231	0.0%	1,102,603	3/31/2020
2019 Q4	2/11/2020	26,643	0.0%	1,102,336	12/31/2019
2014 Q1	5/15/2014	8,512	0.0%	401,700	3/31/2014
2013 Q4	2/14/2014	7,500	0.0%	417,600	12/31/2013